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Case Presentation
A 32-year-old Hispanic female with a past medical history of 
asthma, depression and insomnia presented to the emergency 
room with complaints of right-sided facial droop associated 
with ipsilateral facial numbness and diminished taste for the 
past three days. In addition, she reported a moderate to severe 
pulsatile headache for the past day. This headache was initially 
right-sided and frontal, but then became right-sided and 
occipital in location. She had a history of a similar headache 
episode four years ago. Additionally, she noted moderately 
severe intermittent chest pain described as sharp then dull 
occurring over the past day. On review of systems, the patient 
had similar symptoms of facial droop and numbness without 
alteration in taste, one month prior. At that time, she was 
evaluated at an outside hospital and her symptoms had been 
attributed to a quetiapine-induced acute dystonic reaction 
which was treated with diphenhydramine with resolution of 
symptoms. Additionally, the patient denied sexually transmitted 
diseases, travel or outdoor exposure to tick-borne illnesses. 
Physical examination revealed right-sided facial droop involving 
the corner of the mouth, with sparing of the forehead. She had 
decreased sensation to light touch on the entire right side of 
her face and preservation of sensation on the opposite side. All 
other cranial nerves were intact. The patient’s cardiovascular 
exam was normal. At this point, the differential diagnosis for the 
patient included cerebrovascular accident, intracranial mass/
lesion (tumor, aneurysm, arteriovenous malformation (AVM)) 
compressing cranial nerves V, VII and XII, manifesting itself 
as polycranial neuropathy, atypical Bell’s palsy, Lyme disease, 
atypical episode of migraine headache or neurosyphilis.
Initial laboratory work-up including complete blood count, 
electrolytes, hepatic function panel, lyme antibody, and rapid 
plasma regain (RPR) was unremarkable. Urinalysis and urine 
culture were negative. All imaging including chest radiograph, 
computed tomography (CT) scan without contrast of the head 
and carotid ultrasound was unrevealing. Lastly, a magnetic 
resonance imaging (MRI) of the brain was performed showing 
non-specific changes of the bone marrow, which could correlate 
with anemia or anemia-like states.
Based on the results of her work-up, the patient was diagnosed 
with idiopathic unilateral facial nerve paralysis, Bell’s palsy. 
We will review the work-up and characteristics of idiopathic 
peripheral facial nerve, CN VII palsy, as well as detail the 
differential diagnosis of secondary peripheral facial nerve palsy. 
Differential Diagnosis
Physical examination is essential to differentiate a peripheral 
facial nerve palsy from a central facial nerve palsy.1 The 
peripheral lower motor neuron palsy classically manifests 
as unilateral impairment of movement in the facial muscles, 
drooping of the brow and corner of the mouth, and impaired 
closure of the eye and mouth. These symptoms are ipsilateral 
to the side of the lesion.1 This presentation is in direct contrast 
to a central facial palsy, in which an upper motor neuron deficit 
causes weakness of the lower face contralateral to the side of 
the lesion. The forehead can still be innervated due to both 
ipsilateral and contralateral central innervation of the forehead.1
A diagnosis of true idiopathic peripheral facial palsy, Bell’s palsy, 
is made after exclusion of all other possible etiologies.2 The 
significance of identifying other causes of secondary peripheral 
facial nerve palsy allows specific therapeutic options targeting 
the underlying disease.2 The most common causes of secondary 
peripheral facial nerve palsy along with their characteristic signs, 
symptoms, laboratory and imaging findings are displayed in 
Table 1. 
Management
Eye care of patients with Bell’s palsy focuses on protecting 
the cornea from abrasion and drying due to malfunctioning 
tear production and lid closure.1 Patients are instructed to use 
lubricating drops and ointment, and to report new findings such 
as pain, discharge, or changes in vision to a physician.1
Corticosteroids, including prednisolone, have historically been 
used in the acute phase of Bell’s palsy treatment.1 It has been 
postulated that inflammation and edema lead to paralysis of 
the facial nerve. Thus, anti-inflammatory medications are 
recommended.1 Anti-viral medications, including acyclovir 
and valacyclovir, have also been used concurrently with 
prednisolone based on the aforementioned link between HSV 
and facial paralysis. Until recently there was no strong evidence 
to suggest the impact, if any, that these drugs have on the natural 
course of the disease. 
A 2007 randomized, double-blinded, placebo-controlled trial 
conducted by Sullivan et al., recruited patients with Bell’s palsy 
who presented within 72 hours after onset of symptoms. Patients 
were randomly assigned to receive 10 days of treatment with 
prednisolone, acyclovir, both agents, or placebo. They found that 
early treatment with prednisolone, 50 mg per day for 10 days, 
started within 72 hours of onset significantly improved chances 
of complete recovery at both 3 and 9 months. They did not find 
any evidence of a benefit of acyclovir given alone, or an added 
benefit of acyclovir with prednisolone.3 Other studies, such as 
Engstrom et al., found similar results, but used an initial dose 
of prednisolone 60 mg daily for 5 days followed by a rapid taper 
with a total treatment time of 10 days.4 Based on these studies, if 
a patient presents within 72 hours of onset, prednisolone should 
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be initiated in either of the two described regimens. If a patient 
presents after 72 hours of onset, there is no current evidence to 
suggest that administering prednisolone has any benefit. 
In a 2008 Cochrane review of seven randomized clinical control 
studies performed by Lockhart et al, there was no significant 
difference in the rate of incomplete recovery at one year of 
patients with Bell’s palsy treated with antivirals as compared 
to placebo [RR 0.88 (95% CI 0.65 to 1.18)].5 Furthermore, the 
outcome in patients treated with antivirals was significantly 
worse than those treated with corticosteroids [RR 2.82 (95% CI 
1.09 to 7.32)]. Additionally, there was no significant difference 
in long-term sequelae (i.e. crocodile tears or motor synkineses) 
in the antivirals and corticosteroids group versus the cortico-
steroid monotherapy group.5 Based on these results, antiviral 
medications are not currently recommended as first-line therapy 
for the acute treatment of Bell’s palsy.5 
In addition to pharmacologic therapy, various forms of 
physical therapy, including exercise, mime, biofeedback, laser, 
massage, and electrotherapy, have historically been used in the 
management of acute Bell’s palsy.6 While individualized studies 
have previously demonstrated the efficacy of these techniques7,8 
recent systematic reviews have called into question whether 
physical therapy offers any benefit in time to recovery or reduced 
long-term sequelae as compared to controls.9,10 It is apparent 
that further research with randomized trails are needed to better 
assess whether these techniques should be routinely offered to 
Bell’s palsy patients.6 
Table 1.  Causes of secondary peripheral facial nerve palsy and their respective key diagnostic physical, laboratory  
and imaging findings
Cause History Physical Exam Laboratory Imaging
Lyme disease Tick bite Skin rash (erythema 
chronicum migrans) 
– if it is present, it is 
pathognomonic
Arthritis and  
radiculoneuropathy
IgG/IgM titers
Herpes Simplex Virus-1 
(HSV-1)
Mucosal lesions of mouth, 
gingivae, pharynx, lips 
(recurrent herpes labialis) 
genitals. Herpetic whitlow, 
encephalitis, eye infections
Herpes Zoster Virus Erythematous vesicular 
rash on ear (zoster oticus) 
or in mouth
Trauma History of head trauma or  
intracranial surgery
Tumors Presence of more than one 
CN palsies, e.g. CN VIII 
palsy leading to hearing 
defects/loss
Guillain-Barre Syndrome Prior respiratory tract or 
gastrointestinal infection, 
most commonly  
Campylobacter jejuni
Ascending motor paralysis, 
diminished or absent 
muscle stretch reflexes, 
and sensory loss
Albuminocytologic 
dissociation on CSF 
analysis
Neurosarcoidosis Hypercalcemia, 
elevated serum ACE 
levels, elevated serum 
alkaline phosphatase 
and increased urinary 
calcium excretion
Chest radiography 
and Gallium-67 scan 
to reveal the presence 
of mediastinal/hilar 
enlargement due to 
lymphadenopathy 
and/or interstitial lung 
disease 
HIV Prodrome with fevers, night 
sweats, lymphadenopathy, 
weight loss and myalgias
HIV serology
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